The increased numbers of CD8 T cells showed a strong correlation with the reduced tumour burdens in both AOM/DSS- and APCmin/+ -driven mouse models, indicating an active status of CD8 T cells with an anti-cancer property. The gene discussed is CD8A; the disease is neoplasm.